CD109 and squamous cell carcinoma: In particular, CD109 immunoreactivity was significantly higher in the squamous cell carcinoma cases than in the normal–benign cervical tissue cases (P1 < 0.0001, Mann–Whitney test) and adenocarcinoma cases (P2 = 0.0007, Mann–Whitney test) (Fig. 1b).